Hevi AI, founded in 2020 in Istanbul, is a startup pioneering the integration of deep learning into medical imaging to solve pressing healthcare challenges. Specializing in AI, Health Care, and Medical Devices, the company offers a suite of CE-marked solutions—hStroke, hProstate, hChestXR, and hBreastMMG—designed to rapidly and accurately detect critical conditions like stroke, prostate cancer, lung diseases, and breast cancer.
What distinguishes Hevi AI is its advanced technology and its proven capability to integrate smoothly into diverse clinical workflows—from local clinics to large-scale hospital systems—improving efficiency and patient outcomes. Hevi AI positions itself as a partner in the evolution of radiology.
The company secured a seed investment of $610.00K on 01 January 2024, funded by University Ventures and Aegean Ventures. This strategic investment supports Hevi AI’s mission to remain a key player in transforming radiological practices.